Use of macrolides for the treatment of cancer and macular...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/70 (2006.01) A61K 31/00 (2006.01) A61K 31/7048 (2006.01) A61K 31/7052 (2006.01) A61P 9/10 (2006.01) A61P 35/00 (2006.01) C07H 17/00 (2006.01) C07H 17/08 (2006.01)

Patent

CA 2307850

A method for treating tumors and macular degeneration in a human or veterinary patient comprising administering a compound selected from the group consisting of (I), (II), (III), (IV), (V), (VI), (VII), and a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound thereof.

On décrit un procédé de traitement de tumeurs ou d'une dégénérescence maculaire chez un patient humain ou vétérinaire, qui consiste à administrer un composé sélectionné dans le groupe constitué par les formules (I), (II), (III), (IV), (V), (VI) et (VII). On décrit une composition pharmaceutique contenant un transporteur pharmaceutiquement acceptable ou un composé de ladite composition.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of macrolides for the treatment of cancer and macular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of macrolides for the treatment of cancer and macular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of macrolides for the treatment of cancer and macular... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1613579

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.